Rohini Kuner to be awarded Feldberg Prize


Rohini Kuner is a Full Professor of Pharmacology and Toxicology and the Director of the Institute for Pharmacology at Heidelberg University. She was trained in pharmacology, neuroscience and mouse genetics at the University of Iowa City, USA, the Max Planck Institute for Medical Research, Heidelberg and Heidelberg University.

Prof. Dr. Rohini Kuner, speaker of the Heidelberg Pain Consortium, has received the Feldberg Foundation Prize. With the purpose of promoting scientific contact between German and English scientists within the sphere of experimental medical research, the Feldberg Foundation selects a German and a British laureate each year to establish scientific exchange lectures between the two countries.


Rohini Kuner’s research interests span neurobiological mechanisms underlying chronic pain disorders, elucidation of neural circuits mediating pain and other neurological disorders, cell-cell interactions in the nervous system and development of new strategies for pharmacological therapies. She is particularly known for her work on the molecular neurobiology of pain and has received several national and international scientific awards for uncovering key molecules mediating pain of inflammatory, neuropathic or cancer origin.

News

  • Carmen Ruiz de Almodovar Wins ERC Consolidator Grant

    Congratulations to SFB 1158 Project Leader, Professor Carmen Ruiz de Almodóvar, who has successfully obtained an ERC Consolidator Grant!

     

    Read more ...  
  • Annual International Research Symposium

    Our Annual International Research Symposium took place on December 3, 2019...

    Read more ...  
  • Bonn Researchers Identify Key Proteins for the Repair of Nerve Fibers

    Prof. Dr. Frank Bradke, and his colleagues at the German Center for Neurodegenerative Diseases (DZNE) have identified a group of proteins that help to regenerate damaged nerve cells.

    Read more ...  
  • Memory engrams discovered in the hypothalamus

    Read more ...  
  • Congratulations!

    The Heidelberg Pain Consortium goes into the second funding period.

    Read more ...